.After antibody-drug conjugate (ADC) expert Seagen was actually sold to Pfizer in 2015 for an immens...
.On the heels of a stage 3 win that stopped working to impress capitalists, Ironwood Pharmaceuticals...
.Don't cease Monte Rosa Therapies now. The Boston-based biotech is having a ball after authorizing a...
.Accept to today's Chutes & Ladders, our summary of notable management hirings, firings and retir...
.Commemorating his firm's upsized going public (IPO), Septerna CEO Jeffrey Finer sounded the positio...
.AbbVie has come back to the source of its antipsychotic giant Vraylar seeking an additional hit, sp...
.GenSight Biologics is actually weeks away from lacking loan. Again. The biotech merely has adequate...
.Monopar Rehabs is actually recovering a drug coming from the dump of AstraZeneca's rare condition p...
.Along with brand new data out on Arcus Biosciences' speculative HIF-2a inhibitor, one group of anal...
.After creating a genetics treatment alliance along with Dyno Therapeutics in 2020, Roche is actuall...
.Lundbeck is actually slashing guide value of its $250 thousand Abide Therapies acquistion in feedba...
.The integration of real-world data (RWD) in to procedure usefulness and web site selection has actu...
.At this year's Tough Biotech Top in Boston, our company caught up with forerunners in the biotech f...
.Merck & Co. is actually putting down $30 million in advance to acquire Yale spinout Modifi Biosc...
.Alpha-9 Oncology has actually increased a $175 thousand series C round to stake its own clinical-st...
.Eye drug producer Ocuphire Pharma is obtaining genetics treatment designer Opus Genetics in an all-...
.Roche's chronic coughing plan has faltered to a stop. The drugmaker, which axed the system after th...
.Gilead Sciences as well as Merck & Co. have assisted their once-weekly HIV mixture therapy past ...
.Lykos Rehabs might have dropped three-quarters of its team back the FDA's rejection of its own MDMA...
.Septerna may be actually yet to make known "any meaningful scientific records," however the biotech...